NovaVision, Inc. today launched a free online vision test for stroke and brain injury survivors who wish to learn if a vision deficit exists as a result of their injuries. The interactive test, available at http://www.helpforvisionloss.com/visiontest, provides immediate results to people who want to learn more about their visual acuity.

Boca Raton, Fla. (PRWEB) November 28, 2007 -- NovaVision, Inc. today launched a free online vision test for stroke and brain injury survivors who wish to learn if a vision deficit exists as a result of their injuries. The interactive test, available at http://www.helpforvisionloss.com/visiontest, provides immediate results to people who want to learn more about their visual acuity.

More than 20 percent of Americans who survive a stroke or traumatic brain injury (TBI) suffer from impaired vision. Neurological vision loss can make it difficult for individuals to perform routine tasks like driving, reading and writing, which can dramatically jeopardize their confidence and independence.

NovaVision's online test is a first stop for those who want to learn more about the impact their injuries may have on their sight and how they can improve their vision. Individuals should consider obtaining a comprehensive vision evaluation from a healthcare provider after performing the online vision test. Medical professionals who treat vision loss caused by insults to the brain include neurologists, ophthalmologists, neuro-ophthalmologists and optometrists.

"Historically, visual field testing has not been part of the routine evaluations administered after a stroke or brain injury, yet there are millions of Americans struggling with impaired vision as a result of these experiences," said Navroze Mehta, president and chief executive officer of NovaVision. "By offering this free vision test after stroke or brain injury, we can help people gain control of their rehabilitation."

To help stroke and TBI survivors improve their vision, NovaVision developed Vision Restoration Therapy (VRT), an FDA-cleared medical device designed to stimulate the neurons in the brain responsible for vision. Before undergoing treatment with VRT, patients take a standard diagnostic test at a VRT Center to determine their individual visual field deficits. Shortly following, patients receive a VRT medical device, along with an individualized therapy program to perform at home. Each month, patients receive a more advanced therapy version as their vision progresses. VRT is typically performed for twenty minutes twice a day for about six months. Clinical studies presented at premiere medical meetings, such as the 2007 American Academy of Neurology Meeting and the 2007 International Stroke Conference, show that more than 70 percent of people using VRT saw vision improvements.

VRT is currently available in nearly 50 centers nationwide and more VRT centers are being added routinely. For a list of centers, please visit www.helpforvisionloss.com/centers/directory.
Earlier this year, the Tampa Polytrauma Rehabilitation Center announced it is providing VRT to the thousands of American soldiers returning from the war in Iraq with impaired vision due to TBI.

About NovaVision, Inc.
NovaVision, Inc., headquartered in Boca Raton, Fla., develops and provides scientifically based, innovative medical devices and comprehensive solutions to restore the vision of patients with neurological visual impairments. NovaVision's FDA-cleared Vision Restoration Therapy (VRT) is based on neuroplasticity - the brain's ability to adapt and form new connections to compensate for injury. NovaVision diagnostic testing maps areas where vision may be improved, and therapy targets and stimulates regions within the brain's vision-processing areas.

VRT is based on more than 10 years of research with clinical studies published in leading journals including Nature Medicine, Neurology, and The Journal of Cognitive Neuroscience.

More than 1,000 stroke and traumatic brain injury patients have been treated with NovaVision VRT and clinical results are positive. NovaVision VRT is currently offered at 50 leading neurological, eye and rehabilitation centers nationwide. For more information and a list of centers offering NovaVision VRT, please visit www.helpforvisionloss.com or call 888.205.0800.

###

Simillar Articles

Banyan Biomarkers Announces U.S. Patent for Neural Proteins as Biomarkers for Traumatic Brain Injury

Banyan Biomarkers, Inc. announced today that the U.S. Patent and Trademark Office has granted U.S. Patent No. 7,396,654 B2 “Neural Proteins as Biomarkers for Traumatic Brain Injury,”...

AMA Optics Announces New Panoramic Pinhole - Shows Patients What to Expect From Cataract Surgery

Accurately informing patients of what can be gained from cataract surgery lessens the risk of a poor outcome. For the first time patients can clearly see the improvement they can expect from...

Is Earlier Detection of Cancers Such as Glioma Possible?

Oncolab, Inc.'s AMAS® Test is a commercially available blood test that may allow early detection of a wide range of human cancers. It detects a circulating, cancer-specific antibody, the...

Banyan Biomarkers Announces Issuance of US Patent Relating to Brain Injury Biomarkers

Banyan Biomarkers, Inc. announced today that the U.S. Patent and Trademark Office has granted U.S. Patent No. 7,291,710 "Detection of spectrin and spectrin proteolytic cleavage products in...

President of The Brain Injury Association of Virginia Calls for Summit of All Brain Injury...

President of The Brain Injury Association of Virginia calls for Summit of all Brain injury entities and professionals in response to findings of Joint Legislative Audit and Review Commission...

Home